Mild cognitive impairment and mild dementia: a clinical perspective
- PMID: 25282431
- PMCID: PMC4185370
- DOI: 10.1016/j.mayocp.2014.06.019
Mild cognitive impairment and mild dementia: a clinical perspective
Abstract
Mild cognitive impairment and mild dementia are common problems in the elderly. Primary care physicians are the first point of contact for most patients with these disorders and should be familiar with their diagnosis, prognosis, and management. Both mild cognitive impairment and mild dementia are characterized by objective evidence of cognitive impairment. The main distinctions between mild cognitive impairment and mild dementia are that in the latter, more than one cognitive domain is invariably involved and substantial interference with daily life is evident. The diagnosis of mild cognitive impairment and mild dementia is based mainly on the history and cognitive examination. The prognosis for mild cognitive impairment and mild dementia is an important motivation for diagnosis because in both, there is a heightened risk for further cognitive decline. The etiology of mild cognitive impairment and mild dementia can often be established through the clinical examination, although imaging and other laboratory tests may also contribute. Although Alzheimer disease is the most common cause of both, cerebrovascular disease and Lewy body disease make important contributions. Pharmacological treatments are of modest value in mild dementia due to Alzheimer disease, and there are no approved pharmacological treatments for mild cognitive impairment of any etiology. Nonetheless, new-onset cognitive impairment is a worrisome symptom to patients and families that demands answers and advice. If a patient is having difficulties managing medications, finances, or transportation independently, diagnosis and intervention are necessary to ensure the health and safety of the patient.
Copyright © 2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
Figures

Similar articles
-
Discrete effect of each mild behavioural impairment category on dementia conversion or cognitive decline in patients with mild cognitive impairment.Psychogeriatrics. 2019 Nov;19(6):591-600. doi: 10.1111/psyg.12447. Epub 2019 Mar 19. Psychogeriatrics. 2019. PMID: 30891900
-
Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study.Acta Neurol Scand. 2020 Jun;141(6):500-508. doi: 10.1111/ane.13226. Epub 2020 Feb 27. Acta Neurol Scand. 2020. PMID: 32002988
-
Understanding the role of psychiatrists in the diagnosis and management of mild cognitive impairment and mild Alzheimer's disease dementia: a cross-sectional survey.BMC Psychiatry. 2023 Oct 4;23(1):716. doi: 10.1186/s12888-023-05129-5. BMC Psychiatry. 2023. PMID: 37794326 Free PMC article.
-
Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2021 Jul 27;7(7):CD010783. doi: 10.1002/14651858.CD010783.pub3. Cochrane Database Syst Rev. 2021. PMID: 34313331 Free PMC article.
-
What Are the Key Diagnostic Cognitive Impairment and Dementia Subtypes and How to Integrate all of the Diagnostic Data to Establish a Diagnosis?Clin Geriatr Med. 2023 Feb;39(1):77-90. doi: 10.1016/j.cger.2022.08.002. Clin Geriatr Med. 2023. PMID: 36404034 Review.
Cited by
-
Psychometric Evaluation of the A-NKS: A Diagnostic Instrument to Assess Impairment of Activities of Daily Living in Mild and Major Neurocognitive Disorder According to DSM-5.J Alzheimers Dis. 2024;97(1):373-394. doi: 10.3233/JAD-230627. J Alzheimers Dis. 2024. PMID: 38143348 Free PMC article.
-
Effects of Mild Cognitive Impairment on the Event-Related Brain Potential Components Elicited in Executive Control Tasks.Front Psychol. 2018 May 29;9:842. doi: 10.3389/fpsyg.2018.00842. eCollection 2018. Front Psychol. 2018. PMID: 29910756 Free PMC article. Review.
-
Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology.Neurology. 2023 Nov 7;101(19):842-852. doi: 10.1212/WNL.0000000000207757. Epub 2023 Jul 26. Neurology. 2023. PMID: 37495380 Free PMC article. Review.
-
Phase Angle Is a Potential Novel Early Marker for Sarcopenia and Cognitive Impairment in the General Population.J Cachexia Sarcopenia Muscle. 2025 Jun;16(3):e13820. doi: 10.1002/jcsm.13820. J Cachexia Sarcopenia Muscle. 2025. PMID: 40341877 Free PMC article.
-
Tablet- and Group-Based Multicomponent Cognitive Stimulation for Older Adults With Mild Cognitive Impairment: Single-Group Pilot Study and Protocol for Randomized Controlled Trial.JMIR Res Protoc. 2025 Feb 21;14:e64465. doi: 10.2196/64465. JMIR Res Protoc. 2025. PMID: 39983114 Free PMC article.
References
-
- Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183–94. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical